Cytomx Therapeutics, Inc.
Records under this name other than the patents Cytomx Therapeutics, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 78 patents it holds.
Back to Cytomx Therapeutics, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,255,155 | Antibodies Specific for Urokinase-Type Plasminogen Activator and Methods of Treating Cancer Formerly held In force · High confidence | In force | High confidence | |
| US 11,952,427 | ANTI-CD40 Antibodies and Uses Thereof Formerly held In force · High confidence | In force | High confidence | |
| US 11,220,544 | Anti-CD166 antibodies and uses thereof Lapsed on the fee record Ended Jan 11, 2026 · USPTO record | Lapsed on the fee record | Ended Jan 11, 2026 | USPTO record |
| US 9,856,314 | Activatable antibodies having non-binding steric moieties and methods of using the same Lapsed on the fee record Ended Jan 2, 2026 · USPTO record | Lapsed on the fee record | Ended Jan 2, 2026 | USPTO record |
| US 11,174,316 | ANTI-PDL1 Antibodies, Activatable ANTI-PDL1 Antibodies, and Methods of Use Thereof Lapsed on the fee record Ended Nov 16, 2025 · High confidence | Lapsed on the fee record | Ended Nov 16, 2025 | High confidence |
| US 11,168,144 | Activatable anti-PDL1 antibodies, and methods of use thereof Lapsed on the fee record Ended Nov 9, 2025 · USPTO record | Lapsed on the fee record | Ended Nov 9, 2025 | USPTO record |
| US 8,399,219 | Protease activatable interferon alpha proprotein Lapsed on the fee record Ended Mar 19, 2025 · USPTO record | Lapsed on the fee record | Ended Mar 19, 2025 | USPTO record |
| US 10,894,821 | Activatable antibodies having non-binding steric moieties and methods of using the same Lapsed on the fee record Ended Jan 19, 2025 · USPTO record | Lapsed on the fee record | Ended Jan 19, 2025 | USPTO record |
| US 10,568,977 | Antibodies that bind activatable antibodies and methods of use thereof Lapsed on the fee record Ended Feb 25, 2024 · USPTO record | Lapsed on the fee record | Ended Feb 25, 2024 | USPTO record |
| US 10,513,549 | Cleavage-activatable interferon-alpha proprotein Lapsed on the fee record Ended Dec 24, 2023 · USPTO record | Lapsed on the fee record | Ended Dec 24, 2023 | USPTO record |